Please note: You are viewing legacy versions of Elsevier Library Connect content. A new, revamped Library Connect Web site was launched in January 2012.
Please visit http://libraryconnect.elsevier.com for the latest articles, pamphlets, resources, reports, whitepapers, blog posts, and event listings. Contact us for assistance locating and retrieving articles of interest.

This site search box will look for content as found on our new Library Connect web site.


Library Connect, Partnering with the Library Community. www.elsevier.com/libraryconnect


search this site search web
 View PDF  |     Browse archives
Welcome: Introduction by Randy Charles
Library Connect Home  |  <<  First   |  <  Previous   |   Next  >  |   Last >>
Features

Randy Charles
Randy Charles

Over a decade ago, researchers, clinicians and information providers worldwide were enthusiastically embracing online access to information as a revolution in STM publishing. Indeed, Web access to STM literature was hailed as a revolution on the order of Gutenberg's invention of the printing press.

Today we’re in the midst of a fascinating new phase of what clearly is the ongoing evolution of dissemination of scholarly content. We need just one word to sum up this new phase: mobile.

The main point I’d like to make, in my welcome to this issue on “mobile access,” is that mobile is here and it’s here to stay. Apart from that sweeping generalization, I have the same questions about mobility that we all have.

Addressing diverse aspects of mobility are this issue’s authors, who include:

Reading this issue, I thought about how hard it is to predict the future of STM information access. Our technology and our zeal to improve our lives through technology have raced ahead during the past decade, since MD Consult’s launch in 1997 and ScienceDirect’s launch in 1999.

Where will the next decade take us, as mobile devices become more pervasive and powerful? How will mobility of content change the way we learn, conduct research, treat patients and provide information access?We can’t know for sure.We can simply continue to experiment, and collaborate with our customers to meet their changing needs. And, through publications such as this, built bymany kind contributors, we’ll continue to share the results with each other.

Sincerely,
Randy Charles, Managing Director, Global Clinical Reference Group
Elsevier Health Sciences, Philadelphia, PA, USA
r.charles@elsevier.com